Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382133170> ?p ?o ?g. }
- W4382133170 endingPage "1703" @default.
- W4382133170 startingPage "1703" @default.
- W4382133170 abstract "The introduction of tyrosine kinase inhibitors (TKIs) has changed the treatment paradigm of chronic myeloid leukemia (CML), leading to a dramatic improvement of the outcome of CML patients, who now have a nearly normal life expectancy and, in some selected cases, the possibility of aiming for the more ambitious goal of treatment-free remission (TFR). However, the minority of patients who fail treatment and progress from chronic phase (CP) to accelerated phase (AP) and blast phase (BP) still have a relatively poor prognosis. The identification of predictive elements enabling a prompt recognition of patients at higher risk of progression still remains among the priorities in the field of CML management. Currently, the baseline risk is assessed using simple clinical and hematologic parameters, other than evaluating the presence of additional chromosomal abnormalities (ACAs), especially those at “high-risk”. Beyond the onset, a re-evaluation of the risk status is mandatory, monitoring the response to TKI treatment. Moreover, novel critical insights are emerging into the role of genomic factors, present at diagnosis or evolving on therapy. This review presents the current knowledge regarding prognostic factors in CML and their potential role for an improved risk classification and a subsequent enhancement of therapeutic decisions and disease management." @default.
- W4382133170 created "2023-06-27" @default.
- W4382133170 creator A5008397796 @default.
- W4382133170 creator A5009003698 @default.
- W4382133170 creator A5014181214 @default.
- W4382133170 creator A5016041461 @default.
- W4382133170 creator A5023529754 @default.
- W4382133170 creator A5030933963 @default.
- W4382133170 creator A5031714115 @default.
- W4382133170 creator A5037118724 @default.
- W4382133170 creator A5045537458 @default.
- W4382133170 creator A5063427645 @default.
- W4382133170 creator A5071926851 @default.
- W4382133170 creator A5074800679 @default.
- W4382133170 date "2023-06-23" @default.
- W4382133170 modified "2023-10-14" @default.
- W4382133170 title "Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights" @default.
- W4382133170 cites W1430390330 @default.
- W4382133170 cites W1799579309 @default.
- W4382133170 cites W1901398265 @default.
- W4382133170 cites W1967457266 @default.
- W4382133170 cites W1967685601 @default.
- W4382133170 cites W1968747503 @default.
- W4382133170 cites W1969747807 @default.
- W4382133170 cites W1975975368 @default.
- W4382133170 cites W1978668514 @default.
- W4382133170 cites W1982588049 @default.
- W4382133170 cites W1983618173 @default.
- W4382133170 cites W1985281976 @default.
- W4382133170 cites W1985823023 @default.
- W4382133170 cites W1990406235 @default.
- W4382133170 cites W1995593356 @default.
- W4382133170 cites W1997179318 @default.
- W4382133170 cites W1998406030 @default.
- W4382133170 cites W1998593414 @default.
- W4382133170 cites W1999086939 @default.
- W4382133170 cites W2000445173 @default.
- W4382133170 cites W2009491041 @default.
- W4382133170 cites W2009545306 @default.
- W4382133170 cites W2009972868 @default.
- W4382133170 cites W2010678043 @default.
- W4382133170 cites W2013850642 @default.
- W4382133170 cites W2014364674 @default.
- W4382133170 cites W2016511622 @default.
- W4382133170 cites W2016656445 @default.
- W4382133170 cites W2016809033 @default.
- W4382133170 cites W2019031643 @default.
- W4382133170 cites W2019270541 @default.
- W4382133170 cites W2020094807 @default.
- W4382133170 cites W2021413430 @default.
- W4382133170 cites W2028160317 @default.
- W4382133170 cites W2028332702 @default.
- W4382133170 cites W2028391784 @default.
- W4382133170 cites W2028459384 @default.
- W4382133170 cites W2028669471 @default.
- W4382133170 cites W2033661259 @default.
- W4382133170 cites W2034880840 @default.
- W4382133170 cites W2041053839 @default.
- W4382133170 cites W2041655620 @default.
- W4382133170 cites W2047224624 @default.
- W4382133170 cites W2050904392 @default.
- W4382133170 cites W2053261177 @default.
- W4382133170 cites W2054086725 @default.
- W4382133170 cites W2055663166 @default.
- W4382133170 cites W2065633879 @default.
- W4382133170 cites W2066148382 @default.
- W4382133170 cites W2070375208 @default.
- W4382133170 cites W2072703295 @default.
- W4382133170 cites W2072783250 @default.
- W4382133170 cites W2074198797 @default.
- W4382133170 cites W2075709035 @default.
- W4382133170 cites W2076720738 @default.
- W4382133170 cites W2077220913 @default.
- W4382133170 cites W2083353096 @default.
- W4382133170 cites W2089882703 @default.
- W4382133170 cites W2095235463 @default.
- W4382133170 cites W2096233711 @default.
- W4382133170 cites W2097019092 @default.
- W4382133170 cites W2099747692 @default.
- W4382133170 cites W2101390452 @default.
- W4382133170 cites W2102097468 @default.
- W4382133170 cites W2102999107 @default.
- W4382133170 cites W2104402274 @default.
- W4382133170 cites W2105783133 @default.
- W4382133170 cites W2106266094 @default.
- W4382133170 cites W2107153847 @default.
- W4382133170 cites W2109339644 @default.
- W4382133170 cites W2117806883 @default.
- W4382133170 cites W2118038386 @default.
- W4382133170 cites W2122487233 @default.
- W4382133170 cites W2126816979 @default.
- W4382133170 cites W2127282739 @default.
- W4382133170 cites W2127960841 @default.
- W4382133170 cites W2129970777 @default.
- W4382133170 cites W2136782994 @default.
- W4382133170 cites W2138253305 @default.
- W4382133170 cites W21438611 @default.
- W4382133170 cites W2148743957 @default.